Annual Meeting of Shareholders Summary

Scinai Immunotherapeutics Ltd. held its Annual Meeting of Shareholders on December 22, 2025. Shareholders approved the re-election of Mr. Mark Germain, an amendment to increase the number of authorized Ordinary Shares, and various equity-based awards. These awards included restricted share units for CEO Amir Reichman, options for directors including Mr. Mark Germain, Mr. Adi Raviv, Dr. Yael Margolin, Mr. Samuel Moed, and Mr. Jay Green, as well as options for Prof. Avner Rotman and Dr. Morris Laster upon their stepping down from the Board. Additionally, ADSs were granted to Dr. Tamar Ben-Yedidia for her service. The appointment of Zvi Haft as the Company's auditors for 2025 was also approved and ratified. The total number of ordinary shares entitled to vote was 13,872,899,584, with 2,498,440,000 ordinary shares represented, constituting a quorum. All proposals were approved by the shareholders.